Access cutting-edge multiple sclerosis treatment through this clinical trial at a research site in Los Alamitos. Study-provided care at no cost to qualified participants.
Access multiple sclerosis specialists in Los Alamitos at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple sclerosis treatment provided free
This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥18 years) with RMS, PPMS, or NRSPMS who were previously enrolled in the Phase 2b LTS (LTS16004) or 1 of the 4 Phase 3 tolebrutinib pivotal trials (GEMINI 1 \[EFC16033\], GEMINI 2 \[EFC16034\], HERCULES \[EFC16645\], or PERSEUS \[EFC16035\]). SUBSTUDY: ToleDYNAMIC substudy
Sponsor: Sanofi
Check if you qualify for this multiple sclerosis clinical trial in Los Alamitos, CA
If you're searching for multiple sclerosis treatment options in Los Alamitos, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Alamitos research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.